DOI: 10.1055/s-00000041

Neuropediatrics

References

Haas RH, Nespeca M, Rismanchi N. , et al.
Efficacy of intravenous levetiracetam in neonatal seizures: NEOLEV2–a multicenter, randomized, blinded, controlled phase IIb trial of the optimal dose, efficacy, and safety of levetiracetam compared with phenobarbital in the first-line treatment of neonatal seizures.
In: E-PAS2019: 1770.1. Baltimore, MD: 2019
https://app.core-apps.com/pas2019/abstract/286d6c3548dd83e5cc4e8edf1c3b8dc3 . Accessed July 19, 2019

Haas RH, Nespeca M, Rismanchi N. , et al.
Efficacy of intravenous levetiracetam in neonatal seizures: NEOLEV2–a multicenter, randomized, blinded, controlled phase IIb trial of the optimal dose, efficacy, and safety of levetiracetam compared with phenobarbital in the first-line treatment of neonatal seizures.
In: E-PAS2019: 1770.1. Baltimore, MD: 2019
https://app.core-apps.com/pas2019/abstract/286d6c3548dd83e5cc4e8edf1c3b8dc3 . Accessed July 19, 2019

Download Bibliographical Data

Search in: